Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2024-11-08 00:00:00 ET · period of report 2024-11-06 · accession 0001415889-24-026480 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-08 | 2024-11-06 | AMPH | Liawatidewi Yakob | EVP CORP ADMIN CENTER, Dir | M - OptEx | $13.03 | +5,214 | 80.2K | +7% | +$67.9K |
| D | 2024-11-08 | 2024-11-06 | AMPH | Liawatidewi Yakob | EVP CORP ADMIN CENTER, Dir | S - Sale+OE | $52.05 | -5,214 | 74.9K | -7% | -$271.4K |
| D | 2024-11-08 | 2024-11-06 | AMPH | Liawatidewi Yakob | EVP CORP ADMIN CENTER, Dir | M - OptEx | $0.00 | -5,214 | 11.0K | -32% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-06 | M | A | 5,214 | $13.03 | 80,152 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-06 | S | D | 5,214 | $52.05 | 74,938 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2024-11-06 | M | D | 5,214 | $0.00 | 10,962 | D | $13.03 · — to 2030-03-16 | 5,214 Common Stock | (F3) Shares subject to the option are fully vested and immediately exercisable. |